Comparison of terbutaline and dobutamine in rats with endotoxemia

Chinese Journal of Physiology

Volumn 45, Issue 4, 2002, Pages 155-162

  Wu, Jeng Yuan ^a   Liaw, Wen Jinn ^b   Tzao, Chin ^b   Chen, Shiu Jen ^c   Wang, Jih Hsin ^c   Wu, Chin Chen ^c  

^a Taichung Army General Hospital   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Dobutamine; Lipopolysaccharide; Nitric oxide; Superoxide anion; Terbutaline; Tumor necrosis factor

Indexed keywords

ADENYLATE CYCLASE; BACTERIUM LIPOPOLYSACCHARIDE; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; DOBUTAMINE; ENDOTOXIN; NITRATE; NITRIC OXIDE; SUPEROXIDE; TERBUTALINE; TUMOR NECROSIS FACTOR ALPHA;

ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ATTENUATION; CONTROLLED STUDY; DRUG EFFECT; ENDOTOXEMIA; ENZYME ACTIVATION; ESCHERICHIA COLI; HEMODYNAMIC PARAMETERS; HYPOTENSION; INHIBITION KINETICS; MALE; NONHUMAN; PROTEIN SYNTHESIS; RAT; REVIEW; THORACIC AORTA; VASCULAR DISEASE;

EID: 0037207082     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Altura, B.M., Lefer, A.M. and Schumer, W. Handbook of Shock and Trauma. Vol. 1: Basic Science. NY: Raven Press, 1983.
2. Amezcua, J.L., Palmer, R.M., de Souza, B.M. and Moncada, S. Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit. Br. J. Pharmacol. 97: 1119-1124, 1989.
3. Arai, T., Hiromatsu, K., Kobayashi, N., Takano, M., Ishida, H., Nimura, Y. and Yoshikai, Y. IL-10 is involved in the protective effect of dibutyl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury. J. Immunol. 155: 5743-5749, 1995.
4. Bearn, A.G., Billing, B. and Sherlock, S. The effect of adrenaline and noradrenaline on hepatic blood flow and splanchnic carbohydrate metabolism in man. J. Physiol. 115: 430-441, 1951.
5. Beek, G.C., Oberacker, R., Kapper, S., von Zabern, D., Schulte, J., van Ackern, K., van der Woude, F.J. and Yard, BA. Modulation of chemokine production in lung microvascular endothelial cells by dopamine is mediated via an oxidative mechanism. Am. J. Respir. Cell Mol. Biol. 25: 636-643, 2001.
6. Beckman, J.S., Beckman, T.W., Chen, J., Marshall, P.A. and Freeman, B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87: 1620-1624, 1990.
7. Beutler, B. and Cerami, A. The biology of cachectin/TNFα: a primary mediator of the host response. Ann. Rev. Immunol. 7: 625-655, 1989.
8. Chu, A., Chambers, D.E., Lin, C.C., Kuehl, W.D., Palmer, R.M. and Moncada, S. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dog. J. Clin. Invest. 87: 1964-1968, 1991.
9. Deitsch, E.A. Multiple organ failure: pathophysiology and potential future therapy. Ann Surg 216: 117-134, 1992.
10. Hasko, G., Szabo, C., Nemeth, Z.H., Kvetan, V., Pastores, S.M. and Vizi, E.S. Adenosine receptor agonists differentially regulate IL-10 and TNF production in endotoxemic mice. J. Immunol. 157: 4634-4640, 1996.
11. Hasko, G., Szabo, C., Nemeth, Z.H., Salzman, A.L. and Vizi, E.S. Stimulation of β-adrenoceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice. J. Neuroimmumol. 88: 57-61, 1998.
12. Hayes, M.A., Timmins, A.C., Yau, E.H., Palazzo, M., Hinds, C.J. and Watson, D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N. Engl. J. Med. 330: 1717-1722, 1994.
13. Hoffman, B.B. and Lefkowitz, R.J. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W. and Gilman, A.G. (eds): Goodman & Gilman's The Pharmacological Basis Therapeutics. 9th ed. NY: The McGraw-Hill Co. Inc. 1996, pp 199-248,
14. 2 -Adrenergic activation enhances interleukin-8 production by human monocytes. J. Neuroimmunol. 77: 211-216, 1997.
15. Liao, M.H. and Wu, C.C. Effects of dobutamine on circulatory failure and survival in rats with endotoxemia. J. Med. Sci. 20: 416-428, 2000.
16. Lipton, S.A., Choi, Y.B., Pan, Z.H., Lei, S.Z., Chen, H.S., Sucher, N.J., Loscalzo, J., Singel, D.J. and Stamler, J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature (London) 364: 626-632, 1993.
17. Macarthur, H., Westfall, T.C., Riley, D.P., Misko, T.P. and Salvemini, D. Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc. Natl. Acad. Sci. U.S.A. 97: 9753-9758, 2000.
18. McLean, J.S. and Byrick, R.J. ARDS and sepsis - definitions and new therapy. Can. J. Anesth. 40: 585-590, 1993.
19. Metcalf, K., Jungersten, L. and Lisander, B. Effective inhibition of nitric oxide by aminoguanidine does not reverse hypotension in endotoxemic rats. Acta Anaesthesiol. Scand. 46: 17-23, 2002.
20. Mira, J.P., Fabre, J.E, Baigorri, F., Coste, J., Annat, G., Artigas, A., Nitenberg, G. and Dhainaut, J.F. Lack of oxygen supply dependency in patients with severe sepsis. A study of oxygen delivery increase by military antishock trouser and dobutamine. Chest 106: 1524-1531, 1994.
21. Moncada, S., Palmer, R.M.J., Higgs, E.A. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43: 109-142, 1991.
22. Nathan, C.F. Secretory products of macrophages. J. Clin. Invest. 79: 319-326, 1987.
23. Nathan, C., Xie, QW. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269: 13725-13728, 1994.
24. 2 -Agonists prevent Th 1 development by selective inhibition of interleukin 12. J. Clin. Invest. 100: 1513-1519, 1997.
25. Parker, M.M., Shelhamer, J.H., Natanson, C., Alling, D. and Parillo, J.E. Seroa hemodynamic patterns in survivors and non-survivors of septic shock in humans. Crit. Care Med. 15: 923-929, 1987.
26. Phang, P.T., Cunningham, K.F., Ronco, J.J., Wiggs, B.R. and Russell, J.A. Mathematical coupling explains dependence of oxygen delivery in ARDS. Am. J. Respir. Crit. Care Med. 150: 318-323, 1994.
27. Platzer, C., Meisel, C., Vogt, K., Platzer, M. and Volk, H.D. Up-regulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugs. Int. Immunol. 7: 517-523, 1994.
28. Reinelt, H., Radermacher, P., Fischer, G., Geisser, W., Trunk, E., Wiedeck, H., Mezody, M., Georgieff, M. and Vogt, J. Dobutamine and dopexamine and the splanchnic metabolic response in septic shock. Clin. Intens. Care 8: 38-41, 1997.
29. Repine, J.E. Scientific perspectives on adult respiratory distress syndrome. Lancet 339: 466-469, 1992.
30. Severn, A., Rapson, N.T., Hunter, C.A. and Liew, F.Y. Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. J. Immunol. 148: 3441-3445, 1992.
31. Shoemaker, W.C., Appel, P.L. and Kram, H.B. Hemodynamic and oxygen transport effects of dobutamine in critically ill general surgical patients. Crit. Care Med. 14: 1032-1037, 1986.
32. Silverman, H.J., Penaranda, R., Orens, J.B. and Lee, N.H. Impaired beta-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: association with myocardial hyporesponsiveness to catecholamines. Crit. Care Med. 21: 31-39, 1993.
33. Stoclet, J.C., Fleming, I., Gray, G., Julou-Schaeffer, G., Schneider, F., Schott, C., Schott, C. and Parratt, J.R. Nitric oxide and endotoxemia. Circulation 87(Suppl V): V77-V80, 1993.
34. 2 . J. Exp. Med. 180: 2365-2370, 1994.
35. Sugino, K., Dohi, K., Yamada, K. and Kawasaki, T. Changes in the levels of endogenous antioxidants in the liver of mice with experimental endotoxemia and the protective effects of the antioxidants. Surgery 105: 200-206, 1989.
36. Szabo, C. Alterations in nitric oxide production in various forms of circulatory shock. New Horizons 3: 2-32, 1995.
37. Szabo, C., Hasko, G., Zingarelli, B., Nemeth, Z.H., Salzman, A.L., Kvetan, V., Pastores, S.M. and Vizi, E.S. Isoproterenol regulates tumor necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxemia. Immunology 90: 95-100, 1997.
38. Taffet, S.M., Singhel, K.J., Overholtzer, J.F. and Shurtleff, S.A. Regulation of tumor necrosis factor expression in a macrophage-like cell line by lipopolysaccharide and cyclic AMP. Cell Immunol. 120: 291-300, 1989.
39. Thiemermann, C. The role of the L-arginine: nitric oxide pathway in circulatory shock. Adv. Pharmacol. 28: 45-79, 1994.
40. Thiemermann, C., Wu, C.C., Szabo, C., Perretti, M. and Vane, J.R. Role of tumor necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock. Br. J. Pharmacol. 110: 177-182, 1993.
41. Tracey, K.J. and Cerami, A. Tumor necrosis factor, other cytokines and disease. Anna. Rev. Cell Biol. 9: 317-343, 1993.
42. Vallet, B., Curtis, S.E. and Chopin, C. Prognostic value of the dobutamine test in patients with sepsis syndrome: a prospective multicenter study. Crit. Care Med. 23: 415-416, 1995.
43. Wu, C.C., Chiao, C.W., Hsiao, G., Chen, A and Yen, M.H. Melatonin prevents endotoxin-induced circulatory failure in rats. J. Pineal Res. 30: 147-156, 2001.
44. Wu, C.C., Liao, M.H., Chen, S.J., Chou, T.C., Chen, A. and Yen, M. H. Terbutaline prevents circulatory failure and mitigates mortality in rodents with endotoxemia. Shock 14: 60-67, 2000.
45. Wu, C.C., Liao, M.H., Chen, S.J. and Yen, M.H. Pentoxifylline improves circulatory failure and survival in murine models of endotoxemia. Eur. J. Pharmacol. 373: 41-49, 1999.